Human Vaccines & Immunotherapeutics (Nov 2021)

Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program

Paul Gaston Van Buynder,
Angela Newbound,
C. Raina MacIntyre,
Alexander Thomas Kennedy,
Christopher Clarke,
Jonathan Anderson

Affiliations

Paul Gaston Van Buynder: Griffith University
Angela Newbound: Independent Consultant
C. Raina MacIntyre: University of New South Wales
Alexander Thomas Kennedy: Seqirus Pty Ltd
Christopher Clarke: Seqirus Pty Ltd
Jonathan Anderson: Seqirus Pty Ltd

DOI: https://doi.org/10.1080/21645515.2021.1967042
Journal volume & issue: Vol. 17, no. 11
pp. 4611 – 4616

Abstract

No abstracts available.

Published in Human Vaccines & Immunotherapeutics

ISSN: 2164-5515 (Print); 2164-554X (Online)
Publisher: Taylor & Francis Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy; Medicine: Therapeutics. Pharmacology
Website: https://www.tandfonline.com/journals/khvi

About the journal